Intrahepatic lymphocyte analyses and assessment of the effects of levamisole in murine hepatic metastasis model

Anticancer Research

Volumn 18, Issue 2 A, 1998, Pages 907-910

  Endo, Shungo ^a   Kinoshita, Jun ^a   Yoshimatsu, Kazuhiko ^a   Kato, Hiroyuki ^a   Haga, Shunsuke ^a   Kajiwara, Tetsuro ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

FACS; Intrahepatic lymphocytes; Levamisole; Murine hepatic metastasis model

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; IMMUNOSTIMULATING AGENT; LEVAMISOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER MODEL; CONTROLLED STUDY; DRUG MECHANISM; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER METASTASIS; LIVER NODULE; LYMPHOCYTE; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, SURFACE; LEVAMISOLE; LIVER NEOPLASMS; LYMPHOCYTES; MALE; MICE; MICE, INBRED BALB C;

EID: 0031842054     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Steele GJ, Ravikumar TS: Resection of hepatic metastases from colorectal cancer. Ann Surg 210: 127-138, 1989.
2. Moertel CG, Fleming TR, MacDonald JS, Haller DG, Laurie JA, Goodman PJ, Ungerleider JS, Emerson JA, Tormey DC, Glick HJ, Veeder MH, Mailliard JA: Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322: 352-358, 1990.
3. Laurie JA, Moeltel CG, Fleming TR, Wieand HS, Leigh LE, Rubin J, McCormack GW, Gerstner JB, Krook JE, Malliard J: Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil: the North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol 7: 1447-1456, 1989.
4. Sampson D, Lui A: The effect of levamisole on cell-mediated immunity and suppressor cell function. Cancer Res. 36: 952-955, 1976.
5. Tominaga T, Yoshida Y, Kitamura M, Kosaki G: Liver metastasis of colon 26 cells implanted into the superior mesenteric vein in mice. Jpn J Cancer Res 78: 846-850, 1987.
6. Gomi K, Morimoto M, Nomoto K: Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma. Cancer Res 42: 4197-4202, 1982.
7. Itoh H, Abo T, Sugawara S, Kanno A, Kumagai K: Age-related variation in the proportion and activity of murine liver natural killer cells and their cytotoxicity against regenerating hepatocytes. J Immunol 141: 315-323, 1988.
8. Watanabe H, Ohtsuka K, Kimura M, Ikarashi Y, Ohmori K, Kusumi A, Ohteki T, Seki S, Abo T: Details of an isolation method for hepatic lymphocytes in mice. J Immunol Meth 146: 145-154, 1992.
9. Renoux G: The general immunopharmacology of levamisole. Drugs 19: 89-99, 1980.
10. Groveman DS, Borden EC: In vitro and in vivo effects of levamisole on monocyte chemotaxis in normal donors and patients with colorectal carcinoma. J. Biol. Response Mod 2: 267-274, 1983.
11. Gomi K, Morimoto M, Nomoto K: Influence of surgical removal and effect of levamisole on cytotoxic T-cell-mediated anti-tumor immunity in mice. Cancer Res 43: 5720-5725, 1983.
12. Obiri NI, Dupere SL. Pruett SB: Levamisole meets sulfhydryl requirements of CTLL-2 cells and mediates enhanced proliferative response to mitogen stimulation without increasing interleukin-2 production. J Biol Resp Mod 9: 288-299, 1990.
13. Grem JL, Allegra CJ: Toxicity of levamisole and 5-fluorouracil in human colon carcinoma cells. J Natl Cancer Inst 81: 1413-1417, 1989.
14. Hercend T, Schmidt RE: Characteristics and uses of natural killer cells. Immunol. Today 9: 291-293, 1988.
15. Johnston RB: Monocytes and Macrophages. N Engl Med 318: 747-752, 1988.
16. Yamaki T, Uede T, Shijubo N, Kikuchi K: Functional analysis of mononuclear cells infiltrating into tumors. III. Soluble factors involved in the regulation of T lymphocyte infiltration into tumors. J Immunol 140: 4388-4396, 1988.
17. Shijubo N, Uede T, Kikuchi K: Functional analysis of mononuclear cells infiltrating into tumors. V. A soluble factors involved in the regulation of cytotoxic/suppressor T cell infiltration into tumors. J Immunol 142: 2961-2967, 1989.